Recovery is a round-the-clock process, and you can’t always see a healthcare provider when triggers and cravings arise. reSET® and reSET-O® give you 24/7 support on your smartphone.1,2

reSET

reSET supports your outpatient treatment

reSET, for substance use disorder (SUD), is a 12-week, FDA-authorized prescription digital therapeutic (PDT) clinically proven to help people in outpatient treatment abstain from substance use and stay in treatment longer.1,3

hand reaching for smartphone with reSET app hand reaching for smartphone with reSET app

Meet your digital recovery
companion* for SUD

IN A 12-WEEK CLINICAL STUDY OF PEOPLE WITH SUD

2x

MORE LIKELY

Patients who used reSET in outpatient treatment were 2 times more likely to abstain from substance use than those who didn’t use reSET.1

Treatment with reSET did not demonstrate a significant difference in unanticipated adverse events compared with treatment as usual.3

reSET-O

reSET-O supports your outpatient treatment

reSET-O, for opioid use disorder (OUD), is a 12-week, FDA-authorized PDT clinically proven to help people in outpatient treatment and on transmucosal buprenorphine stay in their treatment longer.2

hand reaching for smartphone with reSET-O app hand reaching for smartphone with reSET-O app

Meet your digital recovery
companion for OUD

IN A 12-WEEK CLINICAL STUDY OF PEOPLE WITH OUD WHO STAYED IN TREATMENT2

82%

Of people who added reSET-O to their buprenorphine stayed in treatment

68%

Who didn’t add reSET-O to their buprenorphine stayed in treatment

The observed adverse events were of a type and frequency to be anticipated in a large population of patients with OUD or associated with buprenorphine pharmacotherapy, particularly during the induction phase.2

The adverse events observed were not determined to be device related.2

Pear Therapeutics logo